查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1427831

2024 年醣體學治療全球市場報告

Glycomic Therapeutics Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

醣體學治療市場規模預計在未來幾年將快速成長。預計到2028年將以16.4%的複合年成長率(CAGR)成長至3,010.3億美元。預測期內的成長可歸因於對糖生物學的更好理解、精準醫學方法的採用、對免疫療法的興趣增加、罕見疾病研究資金的增加以及聚醣生物標記物的出現。預測期內的主要趨勢包括糖組學在腫瘤學中的廣泛應用、改善治療性蛋白質的糖組學工程、糖組學在免疫腫瘤學中的整合、糖組學在罕見和遺傳疾病中的應用以及糖組藥物的監管考量。

糖尿病盛行率的上升預計將推動醣體學治療市場的成長。糖尿病是一種影響血糖（葡萄糖）水平調節的慢性疾病，與觀察到的聚醣變化有關，聚醣變化會導致胰島素阻抗和其他代謝異常。獨特的聚醣模式可作為診斷糖尿病、預測進展和監測治療反應的生物標記。例如，美國國家衛生統計中心報告稱，截至2023年5月，美國18歲及以上成年人被診斷出患有糖尿病的比例從2020年的9.3%上升到2021年的9.6%。糖尿病盛行率的增加推動了醣體學學療法的發展。

癌症發生率的增加預計將推動醣體學治療市場的成長。以不受控制的細胞生長和擴散為特徵的癌症已在醣體學療法中得到應用。這些治療劑可針對並修飾細胞表面的特定糖分子，影響重要的細胞交互作用、訊號途徑和免疫反應，抑制腫瘤生長，提高癌症治療的效果，目的是增強性能力。例如，美國癌症協會報告稱，預計 2023 年美國女性新發肝癌病例數將從 2022 年的 12,660 例增加到 2023 年的 13,230 例。因此，癌症盛行率的增加是推動醣體學學治療市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章市場區隔

  • 全球醣體學療法市場，按類別細分、實際和預測，2018-2023、2023-2028、2033
  • 孤立
  • 合成
  • 全球醣體學治療市場，依結構、實際及預測細分，2018-2023、2023-2028、2033
  • 糖蛋白
  • 唾液酸標靶
  • 蛋白多醣
  • Glico靶點
  • 糖基磷脂醯肌醇 (Gpi) 錨定蛋白和肝素聚醣
  • 鞘醣脂靶點
  • 其他
  • 全球醣體學治療市場，按作用方式、表現和預測細分，2018-2023、2023-2028、2033
  • 神經氨酸酶抑制
  • 乙醯肝素酶和選擇素抑制，阻斷生長因子和硫酸乙醯肝素之間的相互作用
  • 促血紅細胞生長素和酵素替代療法（Ert）
  • 組織胞漿素原活化劑
  • 葡萄糖神經醯胺合成酶抑制
  • 白細胞介素1, 2, 3
  • BETA和γ干擾素
  • 其他
  • 全球醣體學療法市場，按適應症、實際和預測細分，2018-2023、2023-2028、2033
  • 血栓症和化學預防
  • 貧血
  • 抗粘連和發炎特性
  • 白內障
  • 高雪氏症
  • MPS-1 和 IV
  • 癌症
  • 阿茲海默症
  • A 型和 B 型流感
  • 其他

第 7 章 區域與國家分析

  • 全球醣體學治療市場，按地區、績效和預測，2018-2023、2023-2028、2033
  • 全球醣體學治療市場，按國家、績效和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 醣體學治療市場競爭形勢
  • 醣體學治療市場公司概況
    • F Hoffmann-La Roche Ltd.
    • Bayer AG
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
    • GlaxoSmithKline plc

第31章 其他大型創新公司

  • Merck KGaA
  • ICON plc
  • Agilent Technologies Inc.
  • AMS Bio
  • Shimadzu Corporation
  • Waters Corporation
  • Bruker Corporation
  • BioMarin Pharmaceutical Inc.
  • Bio Techne Corp.
  • Promega Corporation
  • Halozyme Therapeutics Inc.
  • Takara Bio Inc.
  • Vector Laboratories
  • New England Biolabs Inc.
  • Protalix Biotherapeutics Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r13675

Glycomic therapeutics involves the application of glycomics-based approaches in the field of therapeutic development. The glycome, which constitutes the complete set of glycans in a cell or organism, plays a crucial role in understanding the intricate nature of biological systems and their implications for health and disease. Glycans are involved in diverse biological processes, including cell signaling, immune responses, and the development of diseases.

The primary types of glycomic therapeutics fall into two classes isolated and synthetic. Isolated glycomic therapy focuses on the study and analysis of glycans in isolation, delving into the structural and functional characterization of individual glycan molecules. Synthetic glycomic therapy involves the use of artificially created glycans or glycan-based molecules for diagnosing and treating various diseases or medical conditions. These therapies target different structures such as glycoproteins, sialic acid, proteoglycans, glycosaminoglycans, glycosylphosphatidylinositol (GPI)-anchored proteins, heparin-based glycans, glycosphingolipids, and others. The mode of action varies, including inhibiting neuraminidase, heparanase, selectins, blocking interactions between growth factors and heparan sulfate, and applications in erythropoietin and enzyme replacement therapy (ERT), tissue plasminogen activator, inhibiting glucosylceramide synthase, and targeting interleukins, interferons, among others. These therapies are employed for indications such as thrombosis and chemoprophylaxis, anemia, anti-adhesive and anti-inflammatory purposes, cataracts, Gaucher's disease, MPS-1 and IV, cancer, Alzheimer's disease, influenza types A and B, and more.

The glycomic therapeutics market research report is one of a series of new reports from The Business Research Company that provides glycomic therapeutics market statistics, including glycomic therapeutics industry global market size, regional shares, competitors with a glycomic therapeutics market share, detailed glycomic therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the glycomic therapeutics industry. This glycomic therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glycomic therapeutics market size has grown rapidly in recent years. It will grow from $141.31 billion in 2023 to $163.73 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to a heightened understanding of the significance of glycans, an increase in chronic diseases, the development of drugs for rare diseases, and collaborative efforts in glycomics research.

The glycomic therapeutics market size is expected to see rapid growth in the next few years. It will grow to $301.03 billion in 2028 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to the increasing understanding of glycan biology, the adoption of precision medicine approaches, growing interest in immunotherapy, higher funding for rare diseases research, and the emergence of glycan biomarkers. Major trends in the forecast period include the broader applications of glycomics in oncology, glycoengineering for improved therapeutic proteins, the integration of glycomics in immuno-oncology, the utilization of glycomics in rare and genetic disorders, and regulatory considerations for glycomic drugs.

The rise in the prevalence of diabetes is anticipated to boost the growth of the glycomic therapeutics market. Diabetes, a chronic medical condition affecting the regulation of blood sugar (glucose) levels, is associated with observed alterations in glycans, contributing to insulin resistance and other metabolic abnormalities. Distinct glycan patterns function as biomarkers for diagnosing diabetes, predicting its progression, and monitoring responses to treatment. For instance, as of May 2023, according to a report from the National Center for Health Statistics, the percentage of diagnosed diabetes in adults aged 18 and over in the United States increased from 9.3% in 2020 to 9.6% in 2021. Therefore, the growth of glycomic therapeutics is driven by the increasing prevalence of diabetes.

The rising incidence of cancer is poised to drive the growth of the glycomic therapeutics market. Cancer, characterized by uncontrolled cell growth and spread, sees applications of glycomic therapeutics in treatment. These therapeutics target and modify specific sugar molecules on cell surfaces, influencing crucial cellular interactions, signaling pathways, and immune responses, with the goal of inhibiting tumor growth and enhancing the effectiveness of cancer therapies. For example, in 2023, the estimated number of new cases of liver cancer in females in the United States increased from 12,660 in 2022 to 13,230 in 2023, as reported by the American Cancer Society. Therefore, the increasing prevalence of cancer is a key factor driving the growth of the glycomic therapeutics market.

Product innovation stands out as a prominent trend gaining traction in the glycomic therapeutics market. Key players in the glycomic therapeutics sector are strategically investing in the development of cutting-edge technologies and innovative solutions to fortify their market position. For example, in April 2022, Glenmark Pharmaceuticals Limited, an Indian-based pharmaceutical company dedicated to discovering advanced therapies, introduced a novel fixed-dose combination (FDC) featuring a DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with Pioglitazone. This innovative combination aims to enhance glycemic control and reduce insulin resistance in patients with type 2 diabetes.

Leading companies in the glycomic therapeutics sector are actively engaged in the creation of groundbreaking technological solutions, such as screening kits, to advance glycobiology research and exploration. A screening kit is a pre-packaged set of tools and materials designed for a preliminary test to detect the presence or absence of a specific substance, condition, or property. For instance, in July 2022, Vector Laboratories, a US-based provider of glycomic solutions, launched Glysite Scout Glycan screening kits. These kits, fully integrated for immunofluorescence, facilitate the detection of glycan expression in tissue sections, allowing researchers to profile and characterize complex glycans in biological systems and identify major surface glycan motifs in a sample.

In May 2022, Halozyme Therapeutics, a US-based biotechnology company, completed the acquisition of Antares Pharma Inc. for $960 million. This strategic move bolstered Halozyme's pipeline portfolio of novel treatments utilizing advanced drug delivery methods, enhancing safety, efficacy, convenience, tolerability, and patient comfort and adherence. Antares Pharma Inc. is a US-based pharmaceutical firm.

Major companies operating in the glycomic therapeutics market report are F Hoffmann-La Roche Ltd., Bayer AG, Sanofi SA, Thermo Fisher Scientific Inc., GlaxoSmithKline PLC, Merck KGaA, ICON PLC, Agilent Technologies Inc., AMS Bio, Shimadzu Corporation, Waters Corporation, Bruker Corporation, BioMarin Pharmaceutical Inc., Bio Techne Corp., Promega Corporation, Halozyme Therapeutics Inc., Takara Bio Inc., Vector Laboratories, New England Biolabs Inc., Protalix Biotherapeutics Inc., Genovis AB, Ray Biotech Life Inc., IEC Group, Ludger Ltd., Z Biotech LLC, Alzheon Inc., GlycoMar Limited

North America was the largest region in the glycomic therapeutics in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomic therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the glycomic therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The glycomic therapeutics market consists of sales of investigational glycomic therapeutics and therapeutic glycomic that target glycans or glycan-related pathways for the diagnosis and treatment of diseases. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Glycomic Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glycomic therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glycomic therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The glycomic therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Class: Isolated; Synthetic
  • 2) By Structures: Glycoproteins; Targeting Sialic Acid; Proteoglycans; Targeting Glycosaminoglycans; Glycosylphosphatidylinositol (GPI)-Anchored Proteins And Heparin Based Glycans; Targeting Glycosphingolipids; Other Structures
  • 3) By Mode Of Action: Inhibits Neuraminidase; Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate; Erythropoietin And Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 And 3; Beta And Gamma Interferons; Other Mode Of Action
  • 4) By Indications: Thrombosis And Chemoprophylaxis; Anemia; Anti-Adhesive And Anti-Inflammatory; Cataracts; Gaucher's Disease; Mps-1 And IV; Cancer; Alzheimer's Disease; Influenza Type A And B; Other Indications
  • Companies Mentioned: F Hoffmann-La Roche Ltd.; Bayer AG; Sanofi SA; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Glycomic Therapeutics Market Characteristics

3. Glycomic Therapeutics Market Trends And Strategies

4. Glycomic Therapeutics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Glycomic Therapeutics Market Size and Growth

  • 5.1. Global Glycomic Therapeutics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Glycomic Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Glycomic Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Glycomic Therapeutics Market Segmentation

  • 6.1. Global Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Isolated
  • Synthetic
  • 6.2. Global Glycomic Therapeutics Market, Segmentation By Structures, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Glycoproteins
  • Targeting Sialic Acid
  • Proteoglycans
  • Targeting Glycosaminoglycans
  • Glycosylphosphatidylinositol (Gpi)-Anchored Proteins And Heparin Based Glycans
  • Targeting Glycosphingolipids
  • Other Structures
  • 6.3. Global Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Inhibits Neuraminidase
  • Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate
  • Erythropoietin And Enzyme Replacement Therapy (Ert)
  • Tissue Plasminogen Activator
  • Inhibits Glucosylceramide Synthase
  • Interleukin 1, 2 And 3
  • Beta And Gamma Interferons
  • Other Mode Of Action
  • 6.4. Global Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Thrombosis And Chemoprophylaxis
  • Anemia
  • Anti-Adhesive And Anti-Inflammatory
  • Cataracts
  • Gaucher's Disease
  • Mps-1 And Iv
  • Cancer
  • Alzheimer's Disease
  • Influenza Type A And B
  • Other Indications

7. Glycomic Therapeutics Market Regional And Country Analysis

  • 7.1. Global Glycomic Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Glycomic Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Glycomic Therapeutics Market

  • 8.1. Asia-Pacific Glycomic Therapeutics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Glycomic Therapeutics Market

  • 9.1. China Glycomic Therapeutics Market Overview
  • 9.2. China Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Glycomic Therapeutics Market

  • 10.1. India Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Glycomic Therapeutics Market

  • 11.1. Japan Glycomic Therapeutics Market Overview
  • 11.2. Japan Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Glycomic Therapeutics Market

  • 12.1. Australia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Glycomic Therapeutics Market

  • 13.1. Indonesia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Glycomic Therapeutics Market

  • 14.1. South Korea Glycomic Therapeutics Market Overview
  • 14.2. South Korea Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Glycomic Therapeutics Market

  • 15.1. Western Europe Glycomic Therapeutics Market Overview
  • 15.2. Western Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Glycomic Therapeutics Market

  • 16.1. UK Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Glycomic Therapeutics Market

  • 17.1. Germany Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Glycomic Therapeutics Market

  • 18.1. France Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Glycomic Therapeutics Market

  • 19.1. Italy Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Glycomic Therapeutics Market

  • 20.1. Spain Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Glycomic Therapeutics Market

  • 21.1. Eastern Europe Glycomic Therapeutics Market Overview
  • 21.2. Eastern Europe Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Glycomic Therapeutics Market

  • 22.1. Russia Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Glycomic Therapeutics Market

  • 23.1. North America Glycomic Therapeutics Market Overview
  • 23.2. North America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Glycomic Therapeutics Market

  • 24.1. USA Glycomic Therapeutics Market Overview
  • 24.2. USA Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Glycomic Therapeutics Market

  • 25.1. Canada Glycomic Therapeutics Market Overview
  • 25.2. Canada Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Glycomic Therapeutics Market

  • 26.1. South America Glycomic Therapeutics Market Overview
  • 26.2. South America Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Glycomic Therapeutics Market

  • 27.1. Brazil Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Glycomic Therapeutics Market

  • 28.1. Middle East Glycomic Therapeutics Market Overview
  • 28.2. Middle East Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Glycomic Therapeutics Market

  • 29.1. Africa Glycomic Therapeutics Market Overview
  • 29.2. Africa Glycomic Therapeutics Market, Segmentation By Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Glycomic Therapeutics Market, Segmentation By Mode Of Action, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Glycomic Therapeutics Market, Segmentation By Indications, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Glycomic Therapeutics Market Competitive Landscape And Company Profiles

  • 30.1. Glycomic Therapeutics Market Competitive Landscape
  • 30.2. Glycomic Therapeutics Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bayer AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sanofi SA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Thermo Fisher Scientific Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlaxoSmithKline plc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Glycomic Therapeutics Market Other Major And Innovative Companies

  • 31.1. Merck KGaA
  • 31.2. ICON plc
  • 31.3. Agilent Technologies Inc.
  • 31.4. AMS Bio
  • 31.5. Shimadzu Corporation
  • 31.6. Waters Corporation
  • 31.7. Bruker Corporation
  • 31.8. BioMarin Pharmaceutical Inc.
  • 31.9. Bio Techne Corp.
  • 31.10. Promega Corporation
  • 31.11. Halozyme Therapeutics Inc.
  • 31.12. Takara Bio Inc.
  • 31.13. Vector Laboratories
  • 31.14. New England Biolabs Inc.
  • 31.15. Protalix Biotherapeutics Inc.

32. Global Glycomic Therapeutics Market Competitive Benchmarking

33. Global Glycomic Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Glycomic Therapeutics Market

35. Glycomic Therapeutics Market Future Outlook and Potential Analysis

  • 35.1 Glycomic Therapeutics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Glycomic Therapeutics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Glycomic Therapeutics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer